Business · 30/08/2017Updated: 10/17/2026 · 1 min read
FDA Withdraws Approval of Upsher-Smith's PROPRANOLOL HYDROCHLORIDE ANDA
Summary
The US Food and Drug Administration (FDA) has withdrawn approval of an abbreviated new drug application for Upsher-Smith Laboratories' PROPRANOLOL HYDROCHLORIDE Extended-Release Capsules, following the company's voluntary request to withdraw the application and waive a hearing.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →